The US Food and Drug Administration warned on Monday that the Johnson & Johnson COVID-19 vaccines may increase the risk of Guillain-Barre syndrome, a rare neurological illness, after 100 early instances were identified among the 12.

COVID-19: Johnson & Johnson vaccine can cause rare neurological complication, warns US FDA

Germany has decided to uplift its prioritization on restrictions on the usage of Johnson & Johnson COVID-19 vaccine. J&J jab will be available for all adults for widespread use across the country. The roll-out of the J&J vaccine had been delayed in Germany and other countries in Europe due to blood clot concerns.

J&J COVID-19 vaccine ready for widespread use in Germany

A Canadian government advisory panel on Monday recommended the use of the Johnson & Johnson vaccine for people aged 30 years and over, despite blood clotting fears. Shelley Deeks of the National Advisory Committee on Immunization (NACI) said the J&J jab has proven to be 'highly effective' in preventing severe COVID-19 infections and hospitalizations.

Canada recommends J&J jab for 30 years and over, despite blood clot fears

For Poles, the May long weekend is usually a time for grilling, socializing and drinking. But in the middle of a pandemic, there is no normal life. So thousands across Poland stood in pouring rain, waiting in line to get a Johnson & Johnson COVID-19 jab instead.

Thousand across Poland stood in the pouring rain for J&J COVID-19 jab

US has approved to restart of Johnson & Johnson COVID-19 vaccine roll out after scientific advisers decided its benefits outweigh a rare risk of blood clot.

Johnson & Johnson vaccines to be restarted in US despite rare clot risk

Italy on Tuesday declared the Johnson & Johnson coronavirus vaccine to be "safe" and said it would prioritise its use for people over 60. The announcement came hours after the European Medicines Agency (EMA) said blood clots should be listed as a "very rare" side effect of the vaccine.

Italy approves J&J vaccine, recommends it for over 60s

While the third-world countries are struggling to get coronavirus vaccine, a factory in the US ruined nearly 15 million doses of the Johnson & Johnson coronavirus vaccines.

US: 15 million doses of Johnson & Johnson coronavirus vaccine destroyed

On Saturday, the US authorised Johnson & Johnson's coronavirus vaccine for emergency use, making it the third approved vaccine of the county since the outbreak of COVID-19 a year ago.

As US approves Johnson & Johnson coronavirus vaccine, Biden warns Americans

South Africa will continue with the planned phase 1 vaccination using the Johnson & Johnson, Health Minister, Zweli Mkhize said today. “Given the outcomes of the efficacy studies, the Department of Health will continue with the planned phase 1 vaccination using the Johnson & Johnson vaccine instead of the AstraZeneca vaccine,” the Minister said in a virtual briefing on Wednesday morning.

South Africa to proceed with planned phase 1 vaccination using J&J

Johnson & Johnson on Thursday applied for emergency use authorisation of its single-dose coronavirus vaccine to US health regulators. If approved, the vaccine will be third for the worst-hit United States, the country which has seen over 450,000 deaths due to the deadly virus.

Johnson & Johnson seeks emergency use authorisation for its Covid-19 vaccine

Johnson & Johnson expects to release critical results from its COVID-19 vaccine trial in as little as two weeks — a potential boon in the effort to protect Americans from the coronavirus — but most likely won’t be able to provide as many doses this spring as it promised the federal government because of unanticipated manufacturing delays.

Johnson & Johnson expects vaccine results soon but lags in production

johnson-johnson-vaccine

Johnson & Johnson Vaccine, News on Johnson & Johnson Vaccine, stories on Johnson & Johnson Vaccine, articles on Johnson & Johnson Vaccine, Johnson & Johnson Vaccine stories at Wion, Johnson & Johnson Vaccine news, Johnson & Johnson Vaccine latest news

johnson johnson-vaccine